Global Kidney Fibrosis Treatment Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Increasing prevalence of obesity and aging population fueling growth of global kidney fibrosis treatment market.

Kidney fibrosis or renal fibrosis is an unavoidable consequence of excessive growth of extracellular matrix that occurs virtually in all types of chronic kidney diseases. Renal scarring results in the progression of loss of renal function, which leads to end-stage renal failure or need for kidney dialysis treatment or transplant. Obesity and smoking are the main causes for increasing incidence of kidney fibrosis globally.

Among the various therapeutic treatments in the market, angiotensin converting enzyme inhibitor is more widely used and revenue from sales of these types of drugs is expected to contribute significantly to growth of the global kidney fibrosis treatment market over the forecast period. Owing to rising disposable income among consumers globally, and rising awareness about accessibility to treatments in hospitals etc., revenue from angiotensin converting enzyme inhibitor is expected to continue its dominance over the forecast period.

Other factors fueling growth of this market include increasing aging population, income saved for long term basis, growing awareness about renal fibrosis treatment, and constant technological innovation leading to development of new, more advanced, safer and effective therapies. Government initiatives for development of novel drugs is expected to fuel growth of the global kidney fibrosis treatment market. Changing lifestyle and food habits are causing a rise in kidney fibrosis patient pools, which is expected to boost demand for kidney fibrosis treatment. Mounting health awareness and health concerns among the growing populations are the factors driving growth of the target market.

Point-of-care drug delivery systems, introduction of personalized medicines, mono-therapeutic approaches or combination therapies are the opportunities expected for growth of kidney fibrosis treatment market. However, high cost involved and failure of treatments are some factors restraining growth of the global kidney fibrosis treatment market to a certain extent. This is a trend expected to continue over the forecast period.

The global kidney fibrosis treatment market report has been segmented on the basis of therapeutics, end user, and region.

North America dominates the global kidney fibrosis treatment market in terms of revenue share, followed by the market in Europe due to large and increasing aging patient pool and improving health facilities globally. Asia Pacific is projected to be the fastest growing market over the forecast period due to increasing medical expenditure, rising medical treatment, and rise in disposable income.

Global kidney fibrosis treatment market segmentation by therapeutic:

 	
Angiotensin converting enzyme inhibitors
 	
Pirfenidone
 	
Renin inhibitors
 	
Angiotensin II receptor blockers
 	
Vasopeptidase inhibitors

Global kidney fibrosis treatment market segmentation by end user:

 	
Clinics
 	
Hospitals
 	
Home based treatment

Global kidney fibrosis treatment market segmentation by region: 

 	
North America
 	
Europe
 	
Asia Pacific
 	
Latin America
 	
Middle East & Africa.

Key players profiled in the global kidney fibrosis treatment market include: 

 	
Hoffmann-La Roche Ltd
 	
Pfizer, Inc.
 	
La Jolla Pharmaceutical Company
 	
Merck & Co.
 	
InterMune, Inc.
 	
Galectin Therapeutics, Inc.
 	
ProMetic Life-Sciences Inc.
 	
Genzyme Corporation
 	
BioLine Rx Ltd

Report Structure:

In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with a list of acronyms and sources used to gather and analyze data and information.

The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others.

The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers.

Objective of Report:

Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries.

Who we are and what we do:

Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies.

Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.